Cargando…
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. Its aggressive nature is attributed partly to its deeply invasive margins, its molecular and cellular heterogeneity, and uniquely tolerant site of origin—the brain. The immunosuppressive central nervous sys...
Autores principales: | Desland, Fiona A., Hormigo, Adília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582539/ https://www.ncbi.nlm.nih.gov/pubmed/33027976 http://dx.doi.org/10.3390/ijms21197358 |
Ejemplares similares
-
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
por: Najem, Hinda, et al.
Publicado: (2021) -
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014) -
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting
por: Vieira de Castro, Joana, et al.
Publicado: (2020) -
The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy
por: Yeo, Erica C. F., et al.
Publicado: (2021) -
The future of cancer immunotherapy for brain tumors: a collaborative workshop
por: Brown, Christine E., et al.
Publicado: (2022)